Medical Condition News

RSS

Treeway, LACDR join forces to optimize clinical trial designs, data-analysis for ALS

Treeway and LACDR at the University of Leiden join forces and form a collaboration focused on the optimization of clinical trial designs and data-analysis for ALS (Amyotrophic Lateral Sclerosis) through the use of population disease progression models.

16 Oct 2014

SIRT6 protein inhibits liver and colon cancers, but promotes skin cancer caused by ultraviolet light

A new study published in Cancer Research shows SIRT6—a protein known to inhibit the growth of liver and colon cancers—can promote the development of skin cancers by turning on an enzyme that increases inflammation, proliferation and survival of sun-damaged skin cells.

16 Oct 2014

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

Across the country, billions of dollars and millions of hours are spent on studying the inner workings of the brain as scientists search for ways to treat debilitating diseases and injuries such as Alzheimer's, Parkinson's, epilepsy, and traumatic brain injury. Now, with the tremendous growth in basic knowledge driven by these efforts, researchers see a need to integrate their work across the broad scientific disciplines represented in modern neuroscience.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

University of Alicante develops tool for people with autism spectrum disorders

The University of Alicante has developed, together with centres in the UK, Spain and Bulgaria, a tool designed to assist people with autism spectrum disorders by adapting written documents into a format that is easier for them to read and understand. This is the main result of the three-year project FIRST (A Flexible Interactive Reading Support Tool), funded by the European Commission under the Seventh Framework Programme.

15 Oct 2014

NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Veterans Affairs for a clinical trial to evaluate the benefits of non-invasive, external Trigeminal Nerve Stimulation (eTNS) for patients with traumatic brain injury (TBI) in a Phase I clinical trial.

15 Oct 2014

Broccoli sprout compound may help ease classic behavioral symptoms in people with autism

Results of a small clinical trial suggest that a chemical derived from broccoli sprouts — and best known for claims that it can help prevent certain cancers — may ease classic behavioral symptoms in those with autism spectrum disorders (ASDs).

15 Oct 2014

OGT's new CytoSure Medical Research Exome Array to be launched at ASHG 2014

Oxford Gene Technology, The Molecular Genetics Company, will launch its CytoSure Medical Research Exome Array at the 64th Annual Meeting of the American Society of Human Genetics 2014, taking place in San Diego on October 18-22.

From Oxford Gene Technology 15 Oct 2014

Scientists create light-activated drug to help control type 2 diabetes

Scientists have created a drug for type 2 diabetes that is switched on by blue light, which they hope will improve treatment of the disease.

15 Oct 2014

Melanoma cells create own 'green light' signal to spread in the body

CANCER RESEARCH UK scientists have discovered that melanoma cells are drawn to follow the 'trail' of a naturally-occurring molecule in the body, which directs this serious type of skin cancer to spread, according to research published today (Tuesday) in PLOS Biology.

15 Oct 2014

Researchers discover new kind of stem cell that may hold clues to origins of liver cancer

A Mount Sinai-led research team has discovered a new kind of stem cell that can become either a liver cell or a cell that lines liver blood vessels, according to a study published today in the journal Stem Cell Reports. The existence of such a cell type contradicts current theory on how organs arise from cell layers in the embryo, and may hold clues to origins of, and future treatment for, liver cancer.

15 Oct 2014

Inflammation in tissue creates a niche for cancer cells

In order to invade healthy tissue, tumor cells must leave the actual tumor and enter the bloodstream or lymphatic system. For this purpose, they use certain enzymes, proteases that break down the tissue surrounding the tumor, thus opening the way for tumor cells to reach blood or lymphatic vessels. To keep the proteases in check, the body produces inhibitors such as the protein TIMP-1, which thwart the proteases in their work.

15 Oct 2014

New research may help identify individuals at increased risk of pancreatic cancer

New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.

15 Oct 2014

UCLA's new collaborative research effort aims to support adolescents, young adults with autism

UCLA, renowned for its leadership in research and treatment for individuals with autism, is launching a first-of-its-kind collaborative research effort to address the health, family and social needs of adolescents and young adults with autism, a group typically overlooked by health care and social services systems.

14 Oct 2014

High doses of fish oil supplements do not reduce atrial fibrillation

High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.

14 Oct 2014

UMMS, UMMSM researchers identify key genetic pathway underlying bipolar disorder

A team of scientists led by researchers at the University of Massachusetts Medical School and the University of Miami Miller School of Medicine have identified what is likely a key genetic pathway underlying bipolar (manic depressive) disorder, a breakthrough that could lead to better drugs for treating bipolar affective disorder, as well as depression and other related mood disorders.

14 Oct 2014

LCSB scientists characterize new tumour suppressor gene

Scientists at the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have published their findings that mutations in a gene known as "ARMC5" promote the growth of benign tumours in the adrenal glands and on the meninges: ARMC5 appears to belong to the group of so-called tumour suppressor genes.

14 Oct 2014

Consultant Live unveils new online sleep disorders educational program for doctors, nurses

UBM Medica US announces that Consultant Live a leading online community for primary care clinicians, has unveiled a new online sleep disorders educational program to help doctors and nurses help their patients get a good night's rest.

14 Oct 2014

Lund University researchers explore personalised treatment for type 2 diabetes

Researchers at Lund University in Sweden are testing a treatment for type 2 diabetes which targets the disease mechanism itself - and not just the symptoms. For the first time, knowledge about the individual patient's genetic risk profile is being used. The treatment completely restores the capacity to secrete insulin, which is impaired by the risk gene.

14 Oct 2014

Dentists at Encino Esthetic Dental Group offer new treatments for patients with TMJ disorders

The team of dentists at Encino Esthetic Dental Group are excited to announce that they now offer new treatments for patients that suffer from TMJ (Temporomandibular Joint) disorders. A new appliance called the NTI is a night guard that covers only the front teeth to increase overall comfort when wearing.

14 Oct 2014

Medical Condition News

Treeway, LACDR join forces to optimize clinical trial designs, data-analysis for ALS

SIRT6 protein inhibits liver and colon cancers, but promotes skin cancer caused by ultraviolet light

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

University of Alicante develops tool for people with autism spectrum disorders

NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial

Broccoli sprout compound may help ease classic behavioral symptoms in people with autism

OGT's new CytoSure Medical Research Exome Array to be launched at ASHG 2014

Scientists create light-activated drug to help control type 2 diabetes

Melanoma cells create own 'green light' signal to spread in the body

Researchers discover new kind of stem cell that may hold clues to origins of liver cancer

Inflammation in tissue creates a niche for cancer cells

New research may help identify individuals at increased risk of pancreatic cancer

UCLA's new collaborative research effort aims to support adolescents, young adults with autism

High doses of fish oil supplements do not reduce atrial fibrillation

UMMS, UMMSM researchers identify key genetic pathway underlying bipolar disorder

LCSB scientists characterize new tumour suppressor gene

Consultant Live unveils new online sleep disorders educational program for doctors, nurses

Lund University researchers explore personalised treatment for type 2 diabetes

Dentists at Encino Esthetic Dental Group offer new treatments for patients with TMJ disorders

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News